IL220907A0 - Production of 6'-o-sialyllactose and intermediates - Google Patents

Production of 6'-o-sialyllactose and intermediates

Info

Publication number
IL220907A0
IL220907A0 IL220907A IL22090712A IL220907A0 IL 220907 A0 IL220907 A0 IL 220907A0 IL 220907 A IL220907 A IL 220907A IL 22090712 A IL22090712 A IL 22090712A IL 220907 A0 IL220907 A0 IL 220907A0
Authority
IL
Israel
Prior art keywords
sialyllactose
intermediates
production
Prior art date
Application number
IL220907A
Original Assignee
Glycom As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycom As filed Critical Glycom As
Publication of IL220907A0 publication Critical patent/IL220907A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IL220907A 2010-02-19 2012-07-12 Production of 6'-o-sialyllactose and intermediates IL220907A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201070061 2010-02-19
PCT/DK2011/050052 WO2011100979A1 (en) 2010-02-19 2011-02-21 Production of 6'-o-sialyllactose and intermediates

Publications (1)

Publication Number Publication Date
IL220907A0 true IL220907A0 (en) 2012-09-24

Family

ID=44482455

Family Applications (1)

Application Number Title Priority Date Filing Date
IL220907A IL220907A0 (en) 2010-02-19 2012-07-12 Production of 6'-o-sialyllactose and intermediates

Country Status (12)

Country Link
US (1) US9237764B2 (en)
EP (1) EP2536736B1 (en)
JP (1) JP2013519694A (en)
KR (1) KR20120138772A (en)
CN (1) CN102822186A (en)
AU (1) AU2011217614A1 (en)
BR (1) BR112012020791A2 (en)
CA (1) CA2789821A1 (en)
IL (1) IL220907A0 (en)
MX (1) MX2012009306A (en)
RU (1) RU2012140011A (en)
WO (1) WO2011100979A1 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013532470A (en) * 2010-07-16 2013-08-19 グリコム アー／エス Synthesis of novel sialo-oligosaccharide derivatives
EP2859112A4 (en) 2012-06-08 2015-10-28 Glycom As Method for producing oligosaccharides and oligosaccharide glycosides by fermentation
EP2861609A4 (en) * 2012-06-14 2015-11-04 Glycom As Enhancing the stability and purity and increasing the bioavailability of human milk oligosaccharides or precursors or blends thereof
GB201306689D0 (en) 2013-04-12 2013-05-29 Glycom As Synthesis of sialylated/fucosylated human milk oligosaccharides
GB201306687D0 (en) * 2013-04-12 2013-05-29 Glycom As Synthesis of sialylated/fucosylated oligosaccharides
EP3041947A4 (en) 2013-09-06 2017-07-26 Glycom A/S Fermentative production of oligosaccharides
DK3209673T4 (en) 2014-10-24 2023-10-02 Glycom As MIXTURES OF HUMAN MILK OLIGOSACCHARIDES
CN107249611A (en) 2014-10-24 2017-10-13 进化生物系统股份有限公司 The Bifidobacterium of activation and its application process
US11040049B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
JP7182872B2 (en) 2014-10-29 2022-12-05 グリコム・アクティーゼルスカブ Synthetic compositions and methods for treatment of irritable bowel syndrome
US11040050B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
US10987368B2 (en) 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
EP3229812A4 (en) 2014-12-08 2018-10-03 Glycom A/S Synthetic composition for treating metabolic disorders
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
WO2016199071A1 (en) 2015-06-09 2016-12-15 Glycom A/S TERNARY MIXTURES OF 6'-SL, LNnT and LST c
PL3349763T3 (en) 2015-09-14 2022-01-03 Glycom A/S Composition for use in microbiota modulation
EP3378868A4 (en) * 2015-11-18 2019-04-17 Kyowa Hakko Bio Co., Ltd. 6'-sialyl lactose sodium salt crystal and method for manufacturing same
CN108289492A (en) 2015-12-15 2018-07-17 雀巢产品技术援助有限公司 The mixture of HMO
EP3419630A4 (en) 2016-02-24 2019-11-06 Glycom A/S Synthetic composition for microbiota modulation
US10899782B2 (en) 2016-03-07 2021-01-26 Glycom A/S Separation of oligosaccharides from fermentation broth
WO2017198276A1 (en) 2016-05-19 2017-11-23 Glycom A/S Synthetic composition
EP3474861A4 (en) 2016-06-24 2020-04-15 Glycom A/S Compositions comprising hmos, their production and use for the prevention and/or treatment of viral and/or bacterial infections
CN106496290B (en) * 2016-10-09 2019-01-18 济南山目生物医药科技有限公司 A kind of preparation method of sialic acid donor
EP3572087B9 (en) * 2017-01-23 2023-10-04 Cupione Co., Ltd. Composition for preventing or treating osteoarthritis containing sialyllactose or salt thereof as active ingredient
WO2018155995A1 (en) * 2017-02-27 2018-08-30 한국생명공학연구원 Antibacterial composition containing sialyllactose as active ingredient
US11278558B2 (en) 2017-03-01 2022-03-22 Glycom A/S Synthetic composition for microbiota modulation
WO2018207110A1 (en) 2017-05-09 2018-11-15 Glycom A/S Synthetic composition for microbiota modulation
US11541067B2 (en) 2017-05-24 2023-01-03 Glycom A/S HMO compositions and methods for reducing detrimental proteolytic metabolites
WO2018215961A1 (en) 2017-05-24 2018-11-29 Glycom A/S Synthetic composition comprising oligosaccharides and its use in medical treatment.
US11524019B2 (en) 2017-08-21 2022-12-13 Glycom A/S Synthetic composition for reducing allergy symptoms
EP3456836A1 (en) 2017-09-13 2019-03-20 Glycom A/S Separation of sialylated oligosaccharides from fermentation broth
US11541069B2 (en) 2017-11-02 2023-01-03 Glycom A/S One or more HMOs for reducing or preventing fatigue and/or improving focus or concentration
JP7327724B2 (en) 2017-11-30 2023-08-16 グリコム・アクティーゼルスカブ A mixture of HMOs to treat wheat sensitivity
CN111432663A (en) * 2017-12-08 2020-07-17 詹尼温生物技术有限责任公司 Spray-dried lacto-N-fucopentan
EP3743078A4 (en) 2017-12-22 2022-01-19 Glycom A/S COMPOSITION COMPRISING HMOs FOR PREVENTING OR REDUCING NOCICEPTION
CN112165947A (en) 2018-05-31 2021-01-01 格礼卡姆股份公司 HMO mixtures for the treatment of autoimmune diseases
WO2021122103A1 (en) * 2019-12-18 2021-06-24 Basf Se Method for reducing the acid content in human milk oligosaccharides
KR20220155595A (en) * 2020-03-20 2022-11-23 글리콤 에이/에스 Methods for providing solid HMO products, and solid HMO products obtained thereby
CN116261398A (en) 2020-10-16 2023-06-13 雀巢产品有限公司 Nutritional composition comprising human milk oligosaccharides
AU2021376858A1 (en) 2020-11-10 2023-04-13 Société des Produits Nestlé S.A. Nutritional composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4990603A (en) 1986-07-04 1991-02-05 Mect Corporation Sialic acid derivatives and process therefor
JP3403205B2 (en) 1996-09-17 2003-05-06 協和醗酵工業株式会社 Process for producing sugar nucleotides and glycoconjugates
FR2796082B1 (en) 1999-07-07 2003-06-27 Centre Nat Rech Scient PROCESS FOR PRODUCING OLIGOSACCHARIDES
US6288222B1 (en) 2000-02-16 2001-09-11 Neose Technologies, Inc. Method of filtration of a dairy stream
US6623954B1 (en) 2002-05-28 2003-09-23 Neose Technologies, Inc. Process for removal of phosphorous from a dairy stream
WO2007090894A1 (en) * 2006-02-10 2007-08-16 Nestec S.A. Oligosaccharide mixture
NL2001377C2 (en) * 2008-03-14 2009-09-15 Friesland Brands Bv Process for isolating sialic acid-containing oligosaccharides, as well as the compositions containing sialic acid-containing oligosaccharides.
IT1394503B1 (en) 2009-04-06 2012-07-05 Inalco Spa SALTS OF 6'-SIALILLATTOSE AND PROCESS FOR THEIR SYNTHESIS AND FOR THE SYNTHESIS OF OTHER ALPHA-SIALYLOLIGOSACCHARIDES.

Also Published As

Publication number Publication date
CA2789821A1 (en) 2011-08-25
US20130035481A1 (en) 2013-02-07
RU2012140011A (en) 2014-03-27
BR112012020791A2 (en) 2016-05-03
KR20120138772A (en) 2012-12-26
MX2012009306A (en) 2012-09-12
WO2011100979A1 (en) 2011-08-25
EP2536736B1 (en) 2017-08-16
CN102822186A (en) 2012-12-12
EP2536736A4 (en) 2013-10-30
JP2013519694A (en) 2013-05-30
US9237764B2 (en) 2016-01-19
EP2536736A1 (en) 2012-12-26
AU2011217614A1 (en) 2012-08-02

Similar Documents

Publication Publication Date Title
IL220907A0 (en) Production of 6'-o-sialyllactose and intermediates
GB201006340D0 (en) Synthesis method and intermediates
EP2828275A4 (en) Synthesis of the trisaccharide 3-o-fucosyllactose and intermediates thereof
ZA201300612B (en) Novel bacteria and methods of use thereof
EP2533636A4 (en) Preparation of benzofurans and use thereof as synthetic intermediates
ZA201208770B (en) New forms of rifaximin and uses thereof
EP2526099A4 (en) Improved process for the preparation of amide intermediates and their use thereof
HUP1000330A2 (en) Process for the preparation of dronedarone and the novel intermediates
EP2444398A4 (en) Novel intermediates of voriconazole and preparation method of voriconazole using the same
IL225687A0 (en) Process for the manufacture of degarelix and its intermediates
PL2632934T3 (en) Process for the manufacture of degarelix and its intermediates
EP2539444A4 (en) Compositions and methods for the production of l-homoalanine
GB201004895D0 (en) Consumables and methods of production thereof
EP2429982A4 (en) Methods of making lubiprostone and intermediates thereof
EP2528923A4 (en) Process for the preparation of darunavir and darunavir intermediates
IL223067A0 (en) Processes and intermediates
GB201004897D0 (en) Consumables and methods of production thereof
GB201004096D0 (en) Production of polyhydroalkanoates
ZA201207878B (en) Consumables and methods of production thereof
EP2576556A4 (en) Process for the synthesis of carbonucleoside and intermediates for use therein
GB201115521D0 (en) Colorant-polyesters and methods of producing colorant-polyesters
EP2637639A4 (en) Transfer resistant cosmetics and method of making
GB201004894D0 (en) Consumables and methods of production thereof
EP2643308A4 (en) Process for the preparation of taurolidine and its intermediates thereof
GB201004902D0 (en) Consumables and methods of production thereof